Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Johnson & Johnson Waits for FDA Ruling on new Diabetes Drug
Motley Fool
Friday, March 29, 2013 - 10:49am
tags:
FDA, JNJ, diabetes, Invokana
Pfizer fails to win dismissal of shareholder class action lawsuit over Celebrex, Bextra
Reuters
Friday, March 29, 2013 - 10:47am
tags:
Pfizer, Celebrex, Bextra, Class Action Lawsuit
U.S. struggles with pharmaceutical goals in Asia trade talks
Reuters
Friday, March 29, 2013 - 10:46am
tags:
Asia
Should AstraZeneca and Bristol-Myers Squibb Get Married?
Motley Fool
Thursday, March 28, 2013 - 11:04am
tags:
Bristol-Myers Squibb, AstraZeneca, M&A
Amgen's And Vical's Melanoma Trials: Questions
Seeking Alpha
Thursday, March 28, 2013 - 10:38am
tags:
Amgen, Vical, melanoma
Aastrom's Shocking News And Future Potential
Seeking Alpha
Thursday, March 28, 2013 - 10:37am
tags:
Aastrom Biosciences
Repros testosterone drug hits main goals of key study
Reuters
Thursday, March 28, 2013 - 10:31am
tags:
Repros Therapeutics, testosterone, Androxal
Common Drug Has The Potential To Slow Aging, Boost Cancer Recovery
Forbes
Thursday, March 28, 2013 - 10:26am
tags:
metformin, Shionogi, Bristol-Myers Squibb, Santarus, Ranbaxy
How Much Will FDA Action On Invokana Affect Johnson And Johnson's Revenue And Stock Price?
Seeking Alpha
Thursday, March 28, 2013 - 10:23am
tags:
JNJ, FDA, Invokana, AstraZeneca, Bristol-Myers Squibb, Merck, Sanofi, Novo Nordisk, Novartis
Pfizer's Bosulif receives conditional marketing authorization from the EC
Yahoo/Fly on the Wall
Thursday, March 28, 2013 - 10:17am
tags:
Pfizer, Europe, Bosulif, chronic myelogenous leukemia
Lyrica's New Role Could Pay Off Big For Pfizer Investors
Seeking Alpha
Thursday, March 28, 2013 - 10:15am
tags:
Lyrica, Pfizer
Zoetis: Will This Successful Spin-off Mean More Spin-offs in the Industry?
Motley Fool
Thursday, March 28, 2013 - 10:14am
tags:
Zoetis, spinoffs, Pfizer, animal health
AP Pharma's drug for chemo-induced nausea denied approval
Reuters
Thursday, March 28, 2013 - 10:12am
tags:
chemotherapy-induced nausea and vomiting, AP Pharma, APF530
4 Stocks Dragging The Drugs Industry Downward
TheStreet.com
Thursday, March 28, 2013 - 8:52am
tags:
Novo Nordisk, Teva, Sanofi, Novartis
Trovagene launches easier test for HPV infection
Yahoo/AP
Thursday, March 28, 2013 - 8:48am
tags:
TrovaGene, HPV, cervical cancer
Anthera Initiates CHABLIS-SC1 Phase 3 Clinical Study in Lupus with Blisibimod
Yahoo
Thursday, March 28, 2013 - 8:47am
tags:
blisibimod, Anthera, lupus
Biogen Wins FDA Approval of MS Pill
TheStreet.com
Thursday, March 28, 2013 - 8:45am
tags:
Biogen Idec, FDA, MS, BG-12, multiple sclerosis, Tecfidera
Ariad Pharma Falls On Weak Leukemia Drug Prescriptions
TheStreet.com
Thursday, March 28, 2013 - 8:40am
tags:
leukemia, Ariad Pharmaceuticals, Iclusig
Recent Melanoma Trial Data Has Biotech Stocks Moving
Seeking Alpha
Wednesday, March 27, 2013 - 12:31pm
tags:
melanoma, Amgen, TVEC, Talimogene Laherparepvec, ImmunoPulse, OncoSec
Verastem Reports Year-End 2012 Financial Results
Yahoo
Wednesday, March 27, 2013 - 12:29pm
tags:
Verastem, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.